TBC1D9B Activators
TBC1D9B activators belong to a class of small molecules or compounds that play a crucial role in regulating cellular processes through the modulation of the TBC1D9B protein. TBC1D9B, also known as Tre-2/Bub2/Cdc16 domain family member 9B, is a protein primarily associated with intracellular trafficking and vesicular transport. It is part of the TBC (Tre-2/Bub2/Cdc16) domain-containing protein family, which acts as GTPase-activating proteins (GAPs) for Rab GTPases, key regulators of vesicle trafficking within cells.
TBC1D9B activators, as the name suggests, are compounds or agents that enhance the activity of TBC1D9B protein. By doing so, they modulate the function of Rab GTPases, which are essential for various cellular processes, including endocytosis, exocytosis, and vesicular transport. These activators may work by binding to TBC1D9B and promoting its GTPase-activating activity, thereby increasing the rate at which Rab GTPases hydrolyze GTP to GDP. This, in turn, regulates the cycling of Rab GTPases between their active GTP-bound form and their inactive GDP-bound form, ultimately influencing the dynamics of intracellular vesicle trafficking. TBC1D9B activators have gained significant attention in cell biology research for their potential to fine-tune cellular processes and shed light on the intricate mechanisms underlying intracellular transport.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a vitamin A metabolite, activates TBC1D9B or related pathways by modulating gene expression. It can stimulate the expression of genes involved in the activation or upregulation of TBC1D9B signaling. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, indirectly increases TBC1D9B activity by influencing gene expression. It leads to the upregulation of genes associated with TBC1D9B-related pathways, thereby promoting its activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine indirectly activates TBC1D9B by inhibiting DNA methylation. This inhibition results in alterations in gene expression patterns, including those linked to the activation of TBC1D9B-related pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, promotes TBC1D9B activation by altering chromatin structure. This alteration facilitates the expression of genes crucial for the activation of TBC1D9B-related pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly increases TBC1D9B activity by elevating cAMP levels and activating protein kinase A. This activation influences genes within TBC1D9B-related pathways, contributing to an enhanced TBC1D9B activation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a phytoestrogen, potentially activates TBC1D9B by binding to estrogen receptors. This interaction modulates gene expression in cells related to TBC1D9B pathways, ultimately promoting TBC1D9B activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates TBC1D9B activity through various signaling pathways, including sirtuins. These pathways indirectly regulate genes involved in TBC1D9B-related processes, resulting in increased TBC1D9B activation. | ||||||